Sponsor Pipeline

Bangdong Gong Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
1
Recruiting
Active Trials by Phase
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT06967038 Chimeric Antigen Receptor Natural Killer Cell Therapy for High-risk Lymphoma Patients… Primary Sjogren's Syndrome Recruiting
Get alerts when Bangdong Gong's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free